4D Molecular Therapeutics, Inc. Quarterly Common Stock, Shares, Outstanding from Q4 2019 to Q3 2024

Taxonomy & unit
us-gaap: shares
Description
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Summary
4D Molecular Therapeutics, Inc. quarterly Common Stock, Shares, Outstanding history and growth rate from Q4 2019 to Q3 2024.
  • 4D Molecular Therapeutics, Inc. Common Stock, Shares, Outstanding for the quarter ending September 30, 2024 was 52M shares, a 21.6% increase year-over-year.
Common Stock, Shares, Outstanding, Quarterly (shares)
Common Stock, Shares, Outstanding, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 52M +9.24M +21.6% Sep 30, 2024 10-Q 2024-11-13
Q2 2024 51.9M +9.9M +23.6% Jun 30, 2024 10-Q 2024-08-08
Q1 2024 51.2M +17.9M +53.9% Mar 31, 2024 10-Q 2024-05-09
Q4 2023 43.1M +10.4M +32% Dec 31, 2023 10-Q 2024-11-13
Q3 2023 42.8M +10.4M +32% Sep 30, 2023 10-Q 2023-11-09
Q2 2023 42M +9.64M +29.8% Jun 30, 2023 10-Q 2023-08-09
Q1 2023 33.2M +973K +3.02% Mar 31, 2023 10-Q 2023-05-11
Q4 2022 32.6M +402K +1.25% Dec 31, 2022 10-K 2024-02-29
Q3 2022 32.4M +5.23M +19.2% Sep 30, 2022 10-Q 2022-11-08
Q2 2022 32.4M +5.49M +20.4% Jun 30, 2022 10-Q 2022-08-11
Q1 2022 32.3M +5.57M +20.9% Mar 31, 2022 10-Q 2022-05-12
Q4 2021 32.2M +5.54M +20.8% Dec 31, 2021 10-K 2023-03-15
Q3 2021 27.2M Sep 30, 2021 10-Q 2021-11-10
Q2 2021 26.9M Jun 30, 2021 10-Q 2021-08-12
Q1 2021 26.7M Mar 31, 2021 10-Q 2021-05-13
Q4 2020 26.7M +21.5M +415% Dec 31, 2020 10-K 2022-03-28
Q4 2019 5.18M Dec 31, 2019 10-K 2021-03-25
* An asterisk sign (*) next to the value indicates that the value is likely invalid.